Inventor · disambiguated record
Peggy Parroche
Also filed as: PARROCHE PEGGY
7 granted patents·4 pending applications·11 citations·filing 2003–2022
74Inventor score
Top patents by PatentIndex Score
11 records- 0194US11974997B2RORgamma modulators and uses thereofGENFIT·Filed 2021·Granted May 7, 2024·7 cites·14 claims
- 0285US11052092B2N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseasesGENFIT·Filed 2018·Granted Jul 6, 2021·3 cites·16 claims
- 0379US12208087B2Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammationGENFIT·Filed 2020·Granted Jan 28, 2025·1 cites·10 claims
- 0458US11160801B2RORgamma modulators and uses thereofGENFIT·Filed 2018·Granted Nov 2, 2021·0 cites·20 claims
- 0558US2024216313A1Elafibranor derivatives agonists of ppar for use in the treatment of sepsisGENFIT·Filed 2022·Application pending·0 cites
- 0650US12391712B2Phosphate derivatives of RORgamma modulators and uses thereofGENFIT·Filed 2020·Granted Aug 19, 2025·0 cites·14 claims
- 0749US2022401420A1Combination therapy having antioxydant propertiesGENFIT·Filed 2020·Application pending·0 cites
- 0845US11077115B2Rorgamma modulators and uses thereofGENFIT·Filed 2018·Granted Aug 3, 2021·0 cites·18 claims
- 0944US2022193042A1Nitazoxanide and thiazolides for use in the treatment of diseases associated with oxidative stressGENFIT·Filed 2020·Application pending·0 cites
- 1042US10987351B2RORgamma modulators and uses thereofGENFIT·Filed 2018·Granted Apr 27, 2021·0 cites·13 claims
- 1140US2006269562A1Polypeptides f' of the hepatitis c virus, t epitopeo, and the diagnostic and therapeutic applications thereofBAIN CHRISTINE·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peggy Parroche files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →